Atlas Trials

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

Clinical trial NCT00692640 · COMPLETED

Trial details

NCT number
NCT00692640
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
CancerNon-small Cell Lung Cancer
Start date
2008-05-01
Primary completion
2011-11-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.